DAA2361 |
major histocompatibility complex, class II, DR beta 4 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB4 |
177.7% Increase Gene Expression Level |
|
DAA2362 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB5 |
184.0% Increase Gene Expression Level |
|
DAA2367 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
parietal lobe |
Human |
HLA-DRB5 |
95.8% Increase Gene Expression Level |
|
DAA2372 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB5 |
64.1% Increase Gene Expression Level |
|
DAA2163 |
major histocompatibility complex, class II, DR beta 6 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB6 |
150.2% Increase Gene Expression Level |
|
DAA2164 |
major histocompatibility complex, class II, DR beta 6 increases with age |
Molecular |
parietal lobe |
Human |
HLA-DRB6 |
33.5% Increase Gene Expression Level |
|
DAA2349 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
22.4% Increase Gene Expression Level |
|
DAA2350 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
32.2% Increase Gene Expression Level |
|
DAA2335 |
major histocompatibility complex, class I-related increases with age |
Molecular |
hippocampus |
Human |
MR1 |
46.6% Increase Gene Expression Level |
|
DAA1416 |
mannose-P-dolichol utilization defect 1 |
Molecular |
hippocampus |
Mouse |
Mpdu1 |
3.0% Increase Gene Expression Level |
|
DAA2348 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
37.9% Increase Gene Expression Level |
|
DAA2165 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
39.5% Increase Gene Expression Level |
|
DAA2340 |
MHC class I polypeptide-related sequence B increases with age |
Molecular |
parietal lobe |
Human |
MICB |
39.9% Increase Gene Expression Level |
|
DAA1224 |
MTHFR methylation decrease |
Molecular |
prefrontal cortex |
Human |
— |
— |
|
DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|
DAA2230 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
parietal lobe |
Human |
MYD88 |
54.8% Increase Gene Expression Level |
|
DAA2242 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
frontal lobe |
Human |
MYD88 |
58.7% Increase Gene Expression Level |
|
DAA2216 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
hippocampus |
Human |
MYD88 |
59.3% Increase Gene Expression Level |
|
DAA1102 |
Myogenic Differentiation 1 |
Molecular |
frontal lobe |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1104 |
Myogenic Differentiation 1 |
Molecular |
temporal lobe |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1389 |
N-acetyltransferase 15 (GCN5-related, putative) |
Molecular |
hippocampus |
Mouse |
Nat15 |
1.0% Decrease Gene Expression Level |
|
DAA2036 |
Neural stem cell pool declines |
Physiological |
hippocampus |
Mouse |
— |
— |
|
DAA1418 |
neuropeptide Y |
Molecular |
hippocampus |
Mouse |
Npy |
3.0% Increase Gene Expression Level |
|
DAA2265 |
NLR family, pyrin domain containing 1 decreases with age |
Molecular |
parietal lobe |
Human |
NLRP1 |
24.8% Decrease Gene Expression Level |
|
DAA2249 |
NLR family, pyrin domain containing 1 decreases with age |
Molecular |
frontal lobe |
Human |
NLRP1 |
29.4% Decrease Gene Expression Level |
|